MedMen Preliminary Third Quarter 2019 Systemwide Revenue Results

MedMen Enterprises Inc. (MMEN.CN) (MMNFF) (FSE:A2JM6N) is planning on announcing its financial results for the third quarter fiscal 2019, which ended on March 30, 2019, on May 29 2019 after market close. Below is a look at their reasonably positive preliminary third quarter 2019 systemwide revenue results. LOS ANGELES–(BUSINESS WIRE)– Enterprises Inc. (“MedMen” or the […]

hTop StockWatch MedMen

MedMen Inc. Due for a Turnaround?

MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: MMNFF) stock seems to have entered into a reasonably predictable pattern resembling a wave function. This has been going on since late November 2018. This behaviour is very unlike MedMen’s previous 6 months, from June through December 2018, with building highs and appropriate lows. The current value is similar to […]

Jesse_Williams-byROBERT MAXWELL

MedMen (CSE: MMEN) (OTCQX: MMNFF) Has a New Commercial

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX:MMNFF) made history yesterday with it’s new commercial that chronicles the U.S’s history with cannabis featuring Jesse Williamsctor best known for his role in popular television series Grey’s Anatomy. Supported by on of the largest integrated marketing campaigns that company has had to date, the commercial […]


MedMen Warrants (MMEN.wt) Worth the Price ?

Lets start right off with our opinion here at Htop Stockwatch we think the MedMen Warrants (MMEN.wt) are currently worth the price of around $0.72. There are 7,840,909 outstanding. With a strike price of $6.87CAD and an expiry of Sept 27th 2021 with no acceleration clause. CSE listing bulletin. The current share price of MedMen […]

High Top Stock Watch

Time to Buy BlackBerry (TSX:BB) Stock?

After many attempts to rekindle their stock price Blackberry (TSE:BB is onto yet another endeavour of increasing its share in the driver less car market. The one-time smartphone leader has just receiving $40 Million in federal funding to help them as they develop tech to make cars more connected, safer, and ultimately capable of […]

High Top Stock Watch

ProMetic Life Sciences(TSE:PLI) Insider Buys $14,800.00

A monumental but likely temporary downtrend is occurring at the moment for ProMetic Life Sciences inc.(TSE:PLI)( I know of one person who would more than likely agree the downtrend is not permanent. As it does not seem to be stopping optimistic insider Martin Leclerc from purchasing $14,800.00 CAD or 20,000 shares of ProMetic Life Sciences […]

Insiders Exude Confidence In Lithium Americas Corp (TSE:LAC)(OTCQX: LACDD)

As a reletivaly unexpected shakeout occurs for Lithium Americas Corp (TSE:LAC)( LACDF) just before their impending NYSE listing (More info here). For some investors this was bad news but if you’re still long this equity rest easy, as it seems the leadership knows something we do not. Insider trading has been relatively positive for Lithium […]

Lithium Americas To Start Trading on NYSE UPDATE

Lithium Americas (TSE: LAC)( LACDF) finally has provided a firm update and precise time they plan to enter the NYSE. This is great news for investors that have been waiting patiently to find out. There have been high hopes, with estimates between 15-20 dollars, for this pure lithium play (the only at the current time). […]

Lithium & Cobalt Demands Rising looks good for Lithium Americas (TSX: LAC.TO) (OTC: LACDD)

Lithium and cobalt prices have been on the rise recently due to worries that the supply of the important [battery producing] metals may not be able to keep up to pace with the increasing demand. November 29, 2017 /PRNewswire/ — Once an unlikely hero in precious metals, cobalt continues to shine and outpace all expectations […]

ProMetic Life Sciences Inc.: TSE:PLI (

ProMetic Life Sciences Inc.: TSE:PLI  has been repeatedly held down but the sentiment seems to be raising ! Comments on popular sites such as stock twits have been increasingly positive investors seem to have high hopes for this one.  ProMetic Life Sciences Inc. (TSE:PLI) had its target price reduced by equities researchers at a variety of firms, […]